Oncogene Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
NRIX | A | Nurix Therapeutics, Inc. | 2.56 | |
TEVA | B | Teva Pharmaceutical Industries | -3.03 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ISRA | C | Market Vectors Israel ETF | 8.86 | |
EIS | C | iShares MSCI Israel Capped Investable Market Index Fund | 7.82 | |
ARKG | F | ARK Genomic Revolution Multi-Sector ETF | 2.99 | |
PPH | C | Market Vectors Pharmaceutical ETF | 2.89 | |
IZRL | C | ARK Israel Innovative Technology ETF | 2.52 |
Compare ETFs
- Oncogene
An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.Most normal cells will undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered and malfunctioning. Activated oncogenes can cause those cells designated for apoptosis to survive and proliferate instead. Most oncogenes began as proto-oncogenes: normal genes involved in cell growth and proliferation or inhibition of apoptosis. If, through mutation, normal genes promoting cellular growth are up-regulated (gain-of-function mutation), they will predispose the cell to cancer; thus, they are termed "oncogenes". Usually multiple oncogenes, along with mutated apoptotic or tumor suppressor genes will all act in concert to cause cancer. Since the 1970s, dozens of oncogenes have been identified in human cancer. Many cancer drugs target the proteins encoded by oncogenes.
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles